Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03964727
Title A Study of Sacituzumab Govitecan in Metastatic Solid Tumors (Tropics-03)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Immunomedics, Inc.

endometrial cancer

lung non-small cell carcinoma

Advanced Solid Tumor

lung small cell carcinoma

head and neck squamous cell carcinoma


Sacituzumab govitecan-hziy

Age Groups: adult | senior
Covered Countries USA | ESP

No variant requirements are available.